Banghula, Mayeth L.
HRN: 29-14-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/18/2026
07/24/2026
IV
500mg
Q8
Surgical Site Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes